Royalty Pharma plc (FRA:RPD)

Market Cap	13.46B
Revenue (ttm)	1.96B
Net Income (ttm)	869.15M
Shares Out	n/a
EPS (ttm)	1.98
PE Ratio	15.49
Forward PE	5.78
Dividend	0.79 (2.54%)
Ex-Dividend Date	Aug 15, 2025

Volume	n/a
Average Volume	n/a
Open	30.72
Previous Close	30.72
Day's Range	30.72 - 30.72
52-Week Range	23.61 - 32.55
Beta	n/a
RSI	40.22
Earnings Date	Nov 7, 2025

About Royalty Pharma

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Country: United Kingdom
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RPD

Financial Performance

In 2024, Royalty Pharma's revenue was $2.26 billion, a decrease of -3.86% compared to the previous year's $2.35 billion. Earnings were $858.98 million, a decrease of -24.31%.

Financial numbers in USD